Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Preventive Formulas Included in Guidelines for Traditional Chinese Medical Treatment of COVID-19

COVID-19 중의 진료지침에 수록된 예방 처방 분석

  • Sanghyun Kim (KM Data Division, Korea Institute of Oriental Medicine) ;
  • Sang-won Shin (Dept. of Humanities & Social Medicine, School of Korean Medicine, Pusan National University) ;
  • Jong-hyun Kim (Dept. of Medical classics and history, College of Korean Medicine, Gachon University)
  • 김상현 (한국한의학연구원 한의약데이터부) ;
  • 신상원 (부산대학교 한의학전문대학원 인문사회의학교실) ;
  • 김종현 (가천대학교 원전의사학교실)
  • Received : 2023.03.31
  • Accepted : 2023.04.25
  • Published : 2023.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : This study collected and analyzed information related to preventive formulas from continuously published and revised COVID-19 treatment guidelines in various regions of China. Methods : We collected treatment guidelines published in different regions of China and categorized formulas for prevention and medical observation period listed in them according to the editions. The categorized preventive formulas were compared by type and target group. Results : Herbal medicines used for prevention included formulas derived from Korean medical classics, such as Okbyeongpungsan(玉屏風散) and Eunkyosan(銀翹散). The newly composed formulas, totaling over 100, were created by adding, subtracting, and combining formulas such as Sang-gukeum(桑菊飮), Eunkyosan(銀翹散), Sasammaekmundongtang(沙參麥門冬湯), Okbyeongpungsan(玉屏風散), Gwakhyangjeong-gisan(藿香正氣散), and Soshihotang(小柴胡湯). Patent medicines including Huoxiangzhengqi capsule(藿香正氣膠囊), Lianhuaqingwen capsule(連花淸瘟膠囊), Shufengjiedu capsule(疏風解毒膠囊), and Jinhuaqinggan granule(金花淸感顆粒) were frequently used, mainly targeting close contacts. These medicines were used differently depending on the specific population group, such as the general population, the elderly, children, pregnant women, and patients with underlying diseases, and were also applied differently according to the individual's constitution. Conclusion : We were able to identify various background factors contained in the guidelines for the use of preventive formulas presented by TCM group, and understand the social conditions that enabled the group to provide such guidelines. Through this, thorough preparation should be made so that the Korean Medicine can actively respond to another future pandemic.

Keywords

Acknowledgement

본 연구는 한국한의학연구원 주요사업 "신변종 바이러스 감염질환 대응 한의 범용 기술 개발(KSN1823223)"의 지원을 받아 수행되었습니다.

References

  1. Lin Y, Cai CZ, Alias H, Wong LP, Hu Z. A cross-sectional survey of self-medication with Traditional Chinese Medicine for treatment and prevention of COVID-19. Complementary therapies in medicine. 2022:71:102898.
  2. Jang S, Kim D, Yi E, Choi G, Song M, Lee EK. Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study. JMIR public health and surveillance. 2021:7(1):e20236.
  3. Zhang Y. Mining the Prescription Patterns and Biological Informatics Research of Traditional Chinese Medicine in the Prevention and Treatment of COVID-19. Beijing University of Traditional Chinese Medicine Master's Degree Thesis. 2021.
  4. Jiang P, Li S, Liu P, Peng J, Peng Q. Analysis of TCM Prevention and Treatment Schemes for COVID-19 in Various Regions of China. Acta Chin Med. 2020:35(4):709-719.
  5. Kim S. The Discussion on Treatment Based on Pattern Identification in Guidelines for Traditional Chinese Medical Treatment of COVID-19 in China. J Physiol & Pathol Korean Med. 2022:36(5):163-168. https://doi.org/10.15188/kjopp.2022.10.36.5.163
  6. Joint Textbook Compilation Committee for Herbal Formula Science in Korean Medicine. Herbal Formula Science in Korean Medicine(1). Paju:Koonja Publishing Inc. 2020:570.
  7. Wu Y, Qi H, Jiang S, Li J, Dong R, Chen G. Feasibility of Yupingfeng Powder in preventing novel coronavirus pneumonia. Chin J Gerontol. 2020:40(8):1769-1772.
  8. Cao R, Ma Q, Xu Q, Duan H, Du L, Ning Y, Ren Y. Potential Common Mechanism of Four Chinese Patent Medicines Recommended by Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7) in Medical Observation Period. Pharmacol & Clin Mater Med. 2020:36(4):2-8.
  9. Gao J, Xiao G, Fan G, Zhang H, Zhu Y, Lu M. Clinical and pharmacological research progress of "three medicines and three formulae" for COVID-19 treatment. Chi Sci Bull. 2022:67(27):3296-3310. https://doi.org/10.1360/TB-2022-0375
  10. Guo C, Jiao H, Li Y. Manifestation of Strengthening Body and Dispelling Pathogenic Factors Rule in TCM with "Three Medicines and Three Prescriptions". J Liaoning Univ Tradit Chin Med. 2020:22(10):159-163.
  11. China Association of Chinese Medicine. Traditional Chinese Medicine Diagnosis and Treatment Guidelines for Severe Acute Respiratory Syndrome (SARS). J Tradit Chin Med. 2003:18(10):865-871.
  12. Jiang D, Zhuo Q, Chen X, Hu J. Enlightenment of Diagnosis and Treatment of SARS in Beijing and Guangzhou. Lishizhen Med & Mater Med Res. 2017:28(5):1167-1169.
  13. Yang H, Xing C, Ji N, Yang Y, Sheng Y. Meta-analysis of Curative Effect of Traditional Chinese Medicine on SARS and Its Implications for the Prevention and Treatment of COVID-19. J Aerosp Med. 2023:34(3):266-269.
  14. Korea Institute of Oriental Medicine. National Traditional Chinese Medicine System of China. Daejeon:KIOM. 2021:254-282.